Filtered By:
Vaccination: Meningitis Vaccine
Countries: Taiwan Health
This page shows you your search results in order of date.
Order by Relevance | Date
Total 29 results found since Jan 2013.
Microbiological and clinical characteristics of Streptococcus pneumoniae serotype 3 infection and risk factors for severe outcome: A multicenter observational study
CONCLUSIONS: Serotype 3 infection showed a high mortality rate, especially in patients with older ages and comorbidities. Although the incidence rates decreased during the COVID-19 pandemic, serotype 3 remained as an important cause of infection after the implementation of PCV13. Developing a more effective vaccine against serotype 3 and monitoring the antimicrobial-resistant sequence types are necessary.PMID:36774315 | DOI:10.1016/j.jmii.2023.01.013
Source: Journal of Microbiology, Immunology, and Infection - February 11, 2023 Category: Microbiology Authors: Merve Arslan Aydin Rajendra Prasad Janapatla Chyi-Liang Chen Hsin-Chieh Li Lin-Hui Su Cheng-Hsun Chiu Source Type: research
Impacts of Catch-Up Immunization program with the 13-Valent pneumococcal Conjugate vaccine in Taiwan: Focus on age-stratified differences and high-risk population (2001-2015)
CONCLUSIONS: Our study suggests that the introduction of this catch-up program with PCV13 was associated with significant declines in the incidence of pneumococcal pneumonia and all-cause pneumonia in vaccinated children, and indirect protection from the program was also found in unvaccinated children.PMID:36127209 | DOI:10.1016/j.vaccine.2022.09.002
Source: Vaccine - September 20, 2022 Category: Allergy & Immunology Authors: Shih-Tsung Huang Yhu-Chering Huang Edward Kuo Ya-Min Yang Fei-Yuan Hsiao Source Type: research
Antimicrobial susceptibility and serotype replacement of Streptococcus pneumoniae in children before and after PCV13 introduction in Taiwan
CONCLUSION: PCV13 was considerably effective in reducing the incidence of IPD in children; however, the prevalence of serotypes 15 A and 23 A increased. The increase in antimicrobial non-susceptibility caused by non-vaccine serotypes must be continuously monitored.PMID:36127232 | DOI:10.1016/j.jmii.2022.08.018
Source: Journal of Microbiology, Immunology, and Infection - September 20, 2022 Category: Microbiology Authors: Hsiang Huang Chien-Yu Lin Nan-Chang Chiu Daniel Tsung-Ning Huang Ching-Ying Huang Hsin Chi Source Type: research
Impacts of Catch-Up Immunization program with the 13-Valent pneumococcal Conjugate vaccine in Taiwan: Focus on age-stratified differences and high-risk population (2001-2015)
CONCLUSIONS: Our study suggests that the introduction of this catch-up program with PCV13 was associated with significant declines in the incidence of pneumococcal pneumonia and all-cause pneumonia in vaccinated children, and indirect protection from the program was also found in unvaccinated children.PMID:36127209 | DOI:10.1016/j.vaccine.2022.09.002
Source: Vaccine - September 20, 2022 Category: Allergy & Immunology Authors: Shih-Tsung Huang Yhu-Chering Huang Edward Kuo Ya-Min Yang Fei-Yuan Hsiao Source Type: research
Antimicrobial susceptibility and serotype replacement of Streptococcus pneumoniae in children before and after PCV13 introduction in Taiwan
CONCLUSION: PCV13 was considerably effective in reducing the incidence of IPD in children; however, the prevalence of serotypes 15 A and 23 A increased. The increase in antimicrobial non-susceptibility caused by non-vaccine serotypes must be continuously monitored.PMID:36127232 | DOI:10.1016/j.jmii.2022.08.018
Source: Journal of Microbiology, Immunology, and Infection - September 20, 2022 Category: Microbiology Authors: Hsiang Huang Chien-Yu Lin Nan-Chang Chiu Daniel Tsung-Ning Huang Ching-Ying Huang Hsin Chi Source Type: research
Impact of pneumococcal conjugate vaccination on hospitalized childhood pneumonia in Taiwan
CONCLUSIONS: Pneumococcal parapneumonic diseases and the disease burden of lobar/pneumococcal pneumonia and lower respiratory tract infections declined after the national PCV13 vaccination program.IMPACT: The impact study of the PCV13 immunization program on childhood pneumonia in Asian countries remained limited. The unique PCV13 immunization program in Taiwan, catch-up before primary infantile series, reduced severe childhood pneumococcal pneumonia at 5 years post PCV13. The intensive and invasive medical needs and fatality of all-cause pneumonia decreased significantly in children of all ages. We observed an increase in...
Source: Pediatric Research - December 23, 2021 Category: Pediatrics Authors: Jian-Te Lee Jou-Wei Lin Ho-Min Chen Chen-Yu Wang Chun-Yi Lu Luan-Yin Chang Li-Min Huang Source Type: research
